SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/14/23 YIELD10 Bioscience, Inc. S-1 7/13/23 3:617K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 492K 2: EX-23.1 Consent of Expert or Counsel HTML 5K 3: EX-FILING FEES Filing Fees HTML 30K
tm2321217-1_s1 - none - 4.859417s |
|
Delaware
|
| |
2870
|
| |
04-3158289
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(IRS Employer
Identification No.) |
|
|
Megan N. Gates, Esq.
Covington & Burling LLP One International Place, Suite 1020 Boston, Massachusetts 02110 (617) 603-8805 |
| | |
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☒ | | | Smaller reporting company ☒ | |
| | | | Emerging growth company ☐ | |
| | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total(1)
|
| |||||||||
Public offering price(2)
|
| | | $ | | | | | $ | | | | | $ | | | |||
Underwriting discounts and commissions(3)
|
| | | $ | | | | | $ | | | | | $ | | | |||
Proceeds, before expenses, to us
|
| | | $ | | | | | $ | | | | | $ | | |
| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 13 | | | |
| | | | | 15 | | | |
| | | | | 17 | | | |
| | | | | 22 | | | |
| | | | | 27 | | | |
| | | | | 30 | | | |
| | | | | 30 | | | |
| | | | | 30 | | | |
| | | | | 31 | | |
|
Platform
|
| |
Product
|
| |
Main Markets
|
| |
Revenue Potential
|
| |
Status
|
|
| Elite Camelina | | | Feedstock oil | | |
▪
Renewable diesel
▪
Aviation biofuel
$27 billion
|
| |
$180 million - $1 billion
|
| |
▪
Early Commercial
▪
Accelerating elite variety development
▪
Focus: US, Canada
▪
Biofuel partner outreach
|
|
| Elite PHA Camelina | | | PHA Bioplastics Feedstock oil | | |
▪
Single use plastic
$200 billion
|
| |
$3.6 billion
|
| |
▪
Trait optimization
▪
Pilot process development
▪
Partner outreach
|
|
| Elite Omega-3 Camelina | | | Omega-3 Oil (DHA+EPA) | | |
▪
Aquaculture feed
▪
Nutrition
$4-6 billion
|
| |
$0.5 billion
|
| |
▪
Pre-commercial development
▪
Partner outreach
|
|
| | |
Actual
|
| |
Pro Forma
|
| |
Pro Forma
As Adjusted(1) |
| |||||||||
| | |
(in thousands)
|
| |||||||||||||||
Cash and cash equivalents
|
| | | $ | 1,809 | | | | | $ | 4,532 | | | | | $ | | | |
Stockholders’ equity: | | | | | | | | | | | | | | | | | | | |
Common stock, $0.01 par value per share: 60,000,000 shares authorized as of March 31, 2023; 5,078,557 shares issued and outstanding as of March 31, 2023; 6,085,267 shares issued and outstanding pro forma
|
| | | | 51 | | | | | | 61 | | | | | | | | |
Additional paid-in capital
|
| | | | 404,803 | | | | | | 407,516 | | | | | | | | |
Accumulated deficit
|
| | | | (403,479) | | | | | | (403,479) | | | | | | | | |
Accumulated other comprehensive loss
|
| | | | (232) | | | | | | (232) | | | | | | | | |
Total stockholders’ equity
|
| | | | 1,143 | | | | | | 3,866 | | | | | | | | |
Total capitalization
|
| | | $ | 1,143 | | | | | $ | 3,866 | | | | | $ | | | |
|
Assumed public offering price per share
|
| | | | | | | | | $ | | | |
|
Historical net tangible book value per share
|
| | | $ | 0.23 | | | | | | | | |
|
Increase per share attributable to pro forma adjustments
|
| | | | 0.41 | | | | | | | | |
|
Pro forma net tangible book value per share at March 31, 2023
|
| | | $ | 0.64 | | | | | | | | |
|
Increase in pro forma net tangible book value per share attributable to new investors
|
| | | | | | | | | | | | |
|
Pro forma as adjusted net tangible book value per share after this offering
|
| | | | | | | | | $ | | | |
|
Dilution per share to investors purchasing securities in this offering
|
| | | | | | | | | $ | | | |
Underwriter
|
| |
Number of
Shares |
| |
Number of
Pre-funded Warrants |
|
Maxim Group LLC
|
| | | | | | |
Total
|
| | | | | | |
| | |
Per Share
|
| |
Per Pre-
Funded Warrant |
| |
Total without
Over- Allotment Option |
| |
Total with
Over- Allotment Option |
| ||||||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Underwriting discount
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Proceeds to us, before expenses(1)
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | |
| | |
Amount to
be paid ($) |
| |||
SEC registration fee
|
| | | $ | 1,322.40 | | |
FINRA filing fee
|
| | | | * | | |
Legal fees and expenses
|
| | | | * | | |
Accounting fees and expenses
|
| | | | * | | |
Other
|
| | | | * | | |
Total
|
| | | $ | * | | |
|
Exhibit
Number |
| |
Exhibit Description
|
| |
Filed
Herewith |
| |
Incorporated
by Reference herein from Form or Schedule |
| |
Filing
Date |
| |
SEC File/
Reg. Number |
|
| 1.1* | | | Underwriting Agreement | | | | | | | | | | | | | |
| 3.1.1 | | | | | | | |
Form 10-Q (Exhibit 3.1)
|
| |
8/9/2018
|
| | | ||
| 3.1.2 | | | | | | | |
Form 8-K (Exhibit 3.1)
|
| |
1/15/2020
|
| | | ||
| 3.2 | | | | | | | |
Form 10-Q (Exhibit 3.1)
|
| |
11/10/2021
|
| | | ||
| 4.1 | | | | | | | |
Form 10-Q (Exhibit 4.1)
|
| |
11/12/2020
|
| | | ||
| 4.2 | | | | | | | |
Form 8-K (Exhibit 4.1)
|
| |
7/5/2017
|
| | | ||
| 4.3 | | | | | | | |
Form S-1/A (Exhibit 4.3)
|
| |
12/15/2017
|
| | | ||
| 4.4 | | | | | | | |
Form 8-K (Exhibit 4.1)
|
| |
11/20/2019
|
| | | ||
| 4.5 | | | | | | | |
Form 8-K
(Exhibit 4.1) |
| |
5/1/2023
|
| | | ||
| 4.6 | | | | | | | |
Form 8-K
(Exhibit 4.1) |
| |
5/4/2023
|
| | | ||
| 4.7 | | | | | | | |
Form 8-K
(Exhibit 4.2) |
| |
5/4/2023
|
| | | ||
| 4.8* | | | Form of Pre-funded Warrant | | | | | | | | | | | | | |
| 5.1* | | | Opinion of Covington & Burling LLP | | | | | | | | | | | | | |
| 10.1† | | | | | | | |
Form S-1/A (Exhibit 10.3)
|
| |
10/20/2006
|
| | | ||
| 10.1.1† | | | | | | | |
Form S-1/A (Exhibit 10.3.1)
|
| |
10/20/2006
|
| | |
|
Exhibit
Number |
| |
Exhibit Description
|
| |
Filed
Herewith |
| |
Incorporated
by Reference herein from Form or Schedule |
| |
Filing
Date |
| |
SEC File/
Reg. Number |
|
| 10.1.2† | | | | | | | |
Form S-1/A (Exhibit 10.3.2)
|
| |
10/20/2006
|
| | | ||
| 10.1.3† | | | | | | | |
Form S-1/A (Exhibit 10.3.3)
|
| |
10/20/2006
|
| | | ||
| 10.2† | | | | | | | |
Form 10-Q (Exhibit 10.1)
|
| |
8/13/2015
|
| | | ||
| 10.2.1† | | | | | | | |
Form 10-K (Exhibit 10.3.1)
|
| |
3/25/2015
|
| | | ||
| 10.2.2† | | | | | | | |
Form 10-K (Exhibit 10.3.2)
|
| |
3/25/2015
|
| | | ||
| 10.2.3† | | | | | | | |
Form 10-K (Exhibit 10.3.3)
|
| |
3/25/2015
|
| | | ||
| 10.3† | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
5/30/2023
|
| | | ||
| 10.3.1† | | | | | | | |
Form 10-K (Exhibit 10.2.5)
|
| |
3/28/2019
|
| | | ||
| 10.3.2† | | | | | | | |
Form 10-K (Exhibit 10.2.6)
|
| |
3/25/2020
|
| | | ||
| 10.4† | | | | | | | |
Form 10-K (Exhibit 10.3)
|
| |
3/30/2017
|
| | | ||
| 10.5† | | | | | | | |
Form 10-K (Exhibit 10.4)
|
| |
3/30/2017
|
| | | ||
| 10.6† | | | | | | | |
Form 10-K (Exhibit 10.6)
|
| |
3/30/2017
|
| | |
|
Exhibit
Number |
| |
Exhibit Description
|
| |
Filed
Herewith |
| |
Incorporated
by Reference herein from Form or Schedule |
| |
Filing
Date |
| |
SEC File/
Reg. Number |
|
| 10.7† | | | | | | | |
Form 10-K (Exhibit 10.8)
|
| |
3/30/2017
|
| | | ||
| 10.8† | | | | | | | |
Form 10-K (Exhibit 10.9)
|
| |
3/30/2017
|
| | | ||
| 10.9† | | | | | | | |
Form S/1/A (Exhibit 10.14)
|
| |
10/20/2006
|
| | | ||
| 10.10 | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
6/17/2015
|
| | | ||
| 10.11 | | | Lease Agreement between the Company and ARE MA Region No. 20, LLC dated January 20, 2016 for the premises located at 19 Presidential Way, Woburn, MA. | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
1/26/2016
|
| | | |
| 10.12 | | | | | | | |
Form 10-K (Exhibit 10.20)
|
| |
3/30/2017
|
| | | ||
| 10.13 | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
7/5/2017
|
| | | ||
| 10.14@ | | | | | | | |
Form 10-Q (Exhibit 10.2)
|
| |
8/9/2018
|
| | | ||
| 10.15 | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
3/15/2019
|
| | | ||
| 10.16 | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
11/20/2019
|
| | |
|
Exhibit
Number |
| |
Exhibit Description
|
| |
Filed
Herewith |
| |
Incorporated
by Reference herein from Form or Schedule |
| |
Filing
Date |
| |
SEC File/
Reg. Number |
|
| 10.17 | | | | | | | |
Form 8-K (Exhibit 10.1)
|
| |
8/25/2020
|
| | | ||
| 10.18@ | | | | | | | |
Form 10-K (Exhibit 10.18)
|
| |
3/14/2023
|
| | | ||
| 10.19 | | | | | | | |
Form 8-K
(Exhibit 10.1)
|
| |
5/1/2023
|
| | | ||
| 10.20 | | | | | | | |
Form 8-K
(Exhibit 10.1)
|
| |
5/4/2023
|
| | | ||
| 21.1 | | | | | | | |
Form 10-K (Exhibit 21.1)
|
| |
3/16/2021
|
| | | ||
| 23.1 | | | | |
X
|
| | | | | | | | | | |
| 23.2 | | | Consent of Covington & Burling LLP (included in Exhibit 5.1). | | | | | | | | | | | | | |
| 24.1 | | | Power of Attorney (included in the signature pages to the registration statement). | | | | | | | | | | | | | |
| 101.INS | | | XBRL Instance Document. | | | | | |
Form 10-K (Exhibit 101.INS)
|
| |
3/14/2023
|
| | | |
| 101.SCH | | | XBRL Taxonomy Extension Schema. | | | | | |
Form 10-K (Exhibit 101.SCH)
|
| |
3/14/2023
|
| | | |
| 101.CAL | | | XBRL Taxonomy Extension Calculation Linkbase. | | | | | |
Form 10-K (Exhibit 101.CAL)
|
| |
3/14/2023
|
| | | |
| 101.DEF | | | XBRL Taxonomy Extension Definition Linkbase. | | | | | |
Form 10-K (Exhibit 101.DEF)
|
| |
3/14/2023
|
| | | |
| 101.LAB | | | XBRL Taxonomy Extension Label Linkbase. | | | | | |
Form 10-K (Exhibit 101.LAB)
|
| |
3/14/2023
|
| | | |
| 101.PRE | | | XBRL Taxonomy Extension Presentation Linkbase. | | | | | |
Form 10-K
(Exhibit 101.PRE) |
| |
3/14/2023
|
| | | |
| 107 | | | | |
X
|
| | | | | | | | | |
| | | | YIELD10 BIOSCIENCE, INC. | | |||
| | | | By: | | |
Oliver P. Peoples
President and Chief Executive Officer |
|
|
|
| |
President, Chief Executive Officer and Director
(Principal Executive Officer) |
| | | |
|
|
| |
Vice President, Finance, and Chief Accounting Officer
(Principal Financial and Accounting Officer) |
| | | |
|
/s/ Sherri M. Brown
|
| | Director | | | | |
|
|
| | Director | | | | |
|
/s/ Willie Loh
|
| | Director | | | | |
|
|
| | Director | | | | |
|
|
| | Chairman | | | |
This ‘S-1’ Filing | Date | Other Filings | ||
---|---|---|---|---|
11/6/28 | ||||
12/31/23 | ||||
11/6/23 | ||||
Filed as of: | 7/14/23 | |||
Filed on: | 7/13/23 | |||
7/12/23 | S-1/A | |||
6/30/23 | 4, S-1 | |||
6/1/23 | ||||
5/18/23 | 8-K | |||
5/12/23 | 10-Q | |||
5/3/23 | 8-K | |||
4/27/23 | 8-K | |||
4/6/23 | DEF 14A | |||
3/31/23 | 10-Q, 4 | |||
1/4/23 | 4 | |||
12/31/22 | 10-K, 4 | |||
12/31/21 | 10-K, 4 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/11/23 YIELD10 Bioscience, Inc. 8-K:1,8,9 8/10/23 12:306K Toppan Merrill/FA 7/21/23 SEC UPLOAD¶ 9/08/23 2:39K YIELD10 Bioscience, Inc. |